Inventor · disambiguated record
Zhong Ma
Also filed as: MA ZHONG
20 granted patents·9 pending applications·95 citations·filing 2013–2025
94Inventor score
Top patents by PatentIndex Score
29 records- 0197US10435438B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Oct 8, 2019·12 cites·21 claims
- 0297US10106579B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·19 cites·20 claims
- 0396US10208089B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·12 cites·21 claims
- 0495US10328115B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·15 cites·22 claims
- 0594US11014965B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted May 25, 2021·3 cites·18 claims
- 0694US10588936B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·13 cites·20 claims
- 0794US9937222B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·14 cites·15 claims
- 0891US10918691B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·2 cites·21 claims
- 0987US12239684B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·13 claims
- 1084US9238676B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·2 cites·20 claims
- 1182US11535650B1Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2022·Granted Dec 27, 2022·0 cites·2 claims
- 1282US10272132B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2018·Granted Apr 30, 2019·1 cites·20 claims
- 1378US11965040B2Modulation of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Apr 23, 2024·0 cites·12 claims
- 1475US11707503B2Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·0 cites·20 claims
- 1575US9644004B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·1 cites·20 claims
- 1674US10954287B2Ras binding peptides and methods of useRA PHARMACEUTICALS INC·Filed 2017·Granted Mar 23, 2021·1 cites·22 claims
- 1765US2025032574A1Neurological disease treatment with zilucoplanRA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1865US2025186541A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 1964US9999650B2Peptide and peptidomimetic inhibitorsRA PHARMACEUTICALS INC·Filed 2017·Granted Jun 19, 2018·0 cites·25 claims
- 2062US11932705B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 19, 2024·0 cites·13 claims
- 2161US2025011368A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 2261US2025049970A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 2360US2025034210A1Dll3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 2452US11505575B2Cyclic polypeptides for PCSK9 inhibitionMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 22, 2022·0 cites·23 claims
- 2551US2022133841A1Neurological disease treatment with zilucoplanRA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2648US2023115176A1Complement Modulators and Related MethodsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2745US2022160820A1Modulators of complement activityRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2843US11814444B2Cyclic polypeptides for PCSK9 inhibitionRA PHARMACEUTICALS INC·Filed 2019·Granted Nov 14, 2023·0 cites·25 claims
- 2943US2025296959A1B7-h3 targeting peptides and constructs thereofMARIANA ONCOLOGY INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhong Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →